Adhesion of ecabet sodium in the form of enteric coated capsule to the surface of small intestine.
- Conditions
- Healthy volunteers
- Registration Number
- JPRN-UMIN000001801
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Not provided
1. Organic disease(Reflux esophagitis, Peptic ulcer disease, Erosive gastritis) 2. Past history of GI resection surgery other than appendectomy. 3. Intestinal lesions such as Crohn's disease, Behcet disease. 4. Patients with pace maker or with other electric device in the body 5. NSAIDs user, Patients with severe stress conditions 6. Organic disease in brain, Depression and Schizophrenia 7. Alcoholics and Drug dependence 8. Hyperthyroidism 9. Severe heart, liver and kidney diseases or infectious diseases 10. Drug allergy for ecabet sodium 11. Expectant mother, Breast feeding mother 12. Drug (anti-secretory drugs, prokinetics, antacid, anti-cholinergic agents, tranquilizer, anti-depressant)users within a week before the entry. 13. Subjects recognized as not suitable to the test by doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the adhesive ability of ecabet sodium in the form of enteric coated capsule with that in the form of conventional granules to small intestine
- Secondary Outcome Measures
Name Time Method